WASHINGTON – Swiss pharmaceutical maker Novartis AG will stop selling a drug to relieve constipation after it was linked to a higher chance of heart attack, stroke and worsening chest pain that can become a heart attack, federal health officials said. Novartis agreed to withdraw… Read More
Comments for: Studies link Zelnorm to heart attacks Company pulls prescription constipation drug after request from FDA
Studies link Zelnorm to heart attacks Company pulls prescription constipation drug after request from FDA
You may also like
Studies link Zelnorm to heart attacks Company pulls prescription constipation drug after request from FDA